Top Houston, TX Pharmaceutical Companies (29)
Don't see your company?
Create a company profile
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets.
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
PCCA is a complete resource for compounding pharmacies. Our members are nearly 4,000 community pharmacists in the United States, Canada, Australia and other countries around the world. We were incorporated in 1981 by a network of pharmacists who recognized the need to help patients requiring customized medications.
Animal Life Sciences focuses on the development and commercialization of treatments for cats and dogs based on human cancer technologies.
Memgen is developing viral immunotherapies to harness the power of the immune system to cure cancer and protect people from COVID-19
Medical Research Consultants (MRC) specializes in Record Retrieval & Management, Nurse Audits & Analysis, and Regulatory Compliance services to Legal, Pharmaceutical, Healthcare & Corporate entities. MRC’s diverse solutions are backed with more than two decades of expertise, and customized to our clients’ business goals. As a nationally certified Women's Business Enterprise and employee-owned business, MRC is committed to leveraging the strengths of our employees to exceed client expectations while fostering a healthy company culture and contributing to our clients’ success. Our commitment to excellence has been rewarded by preferred partnerships with global corporations, as well as continuing relationships with multiple AmLaw 100 firms.
We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient’s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies. Marker is also advancing a number of innovative peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including our Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and our HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In parallel, we are developing a proprietary DNA expression technology named PolyStart™ to improve the ability of the cellular immune system to recognize and destroy diseased cells.
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
We are located near the Texas Medical Center in Houston, Texas. Under the leadership of Alice S. Weissfeld, Ph.D., D (ABMM), and Paula H. Vance, SM(NRM), SM(ASCP), CLS(M), msi has remained in the forefront of microbiology testing since 1984 and maintains a reputation for scientifically reliable testing. Originally founded as a clinical microbiology reference laboratory, msi subsequently expanded its services to include environmental microbiology and pharmaceutical and diagnostic trials. MSI has built a strong reputation as a central microbiology lab. Our heritage of scientific and therapeutic excellence translates to the highest standards for our sponsors. Dr. Weissfeld reviews all testing methods and schema to ensure the most efficient and effective study design. We routinely add new tests and evaluate industry trends in order to build our capabilities to support client needs. We offer scientific expertise related to: Protocol consultation Veterinarian Clinical Trials Medical Device Pharmaceutical Please contact us today to discuss your Microbiology needs for any type of clinical trial or USP Compliance.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
Kiromic develops biomarker- and small molecule-based diagnostic and therapeutic programs for solid tumors and hematologic malignancies.
Wells Pharma is a registered FDA 503B Outsourcing Facility providing medications to hospitals and surgical centers. Our mission is to consistently supply top quality products with the best customer service in the industry.
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
Clinical stage pharmaceutical company developing topical, non-narcotic medications to treat pain.
Pharm-Olam is a global CRO that is dedicated to helping Sponsors create a healthier world through the development of life-changing treatments.
Nano3D Biosciences develops products for in vitro cell culturing applications.
QuVa Pharma is a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. QuVa was purpose-built to change the 503B industry for the better and is leading the way in making it more safe, efficient, and reliable. With unmatched expertise in cGMPs and sterile pharmaceutical manufacturing, we achieve higher than required quality and safety standards and maintain a leading FDA compliance record, so hospitals can more confidently and reliably focus on patient care. While our leading cGMP processes, sterile-to-sterile portfolio, and expansive capacity of 300,000 sq ft across four facilities are the foundation of success, it is our transparency, customer-focused service, and contracted supply arrangements that enable us to help hospitals and health systems better meet their patient care and operational needs. As FDA compliance becomes more stringent, QuVa's ability to reliably supply the highest-quality products is more valuable than ever and allows hospitals to spend more time on patient care and less time worried about beyond use dates, waste, workload inefficiencies, and compliance. That is why QuVa is proud to be recognized as the partner of choice for many of the nation’s leading health systems. So, whether you are calling for a response or being called on for a solution, know that QuVa is accountable, and in us, you always have an answer.
Work Your Passion. Live Your Purpose.
